Anette Sundstedt
Keine laufenden Positionen mehr
Profil
Anette Sundstedt served as a Director at Active Biotech AB from 2001 to 2016.
She also held the position of Director at Alligator Bioscience AB from 2021 to 2024.
Dr. Sundstedt was the Chief Scientific Officer at Idogen AB.
Additionally, she served as the Chief Development Officer at CanImGuide Therapeutics AB from 2020 to 2021.
Dr. Sundstedt obtained her graduate and doctorate degrees from the University of Lund.
Ehemalige bekannte Positionen von Anette Sundstedt
| Unternehmen | Position | Ende |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Direktor/Vorstandsmitglied | 07.05.2024 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Corporate Officer/Principal | 01.03.2021 |
| ACTIVE BIOTECH AB | Direktor/Vorstandsmitglied | 01.01.2016 |
| IDOGEN AB (PUBL) | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Anette Sundstedt
| University of Lund | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| IDOGEN AB (PUBL) | Health Technology |
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
